Business · 22/07/2024Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on XENPOZYME Patent Extension
Summary
The FDA is correcting a notice that incorrectly stated the patent number for XENPOZYME, a medication, in a July 2, 2024, Federal Register announcement about patent extension.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →